Ypsomed Holding AG (YPSN) - Total Assets

Latest as of September 2025: CHF1.21 Billion CHF ≈ $1.53 Billion USD

Based on the latest financial reports, Ypsomed Holding AG (YPSN) holds total assets worth CHF1.21 Billion CHF (≈ $1.53 Billion USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See what is Ypsomed Holding AG's book value for net asset value and shareholders' equity analysis.

Ypsomed Holding AG - Total Assets Trend (2002–2025)

This chart illustrates how Ypsomed Holding AG's total assets have evolved over time, based on quarterly financial data.

Ypsomed Holding AG - Asset Composition Analysis

Current Asset Composition (March 2025)

Ypsomed Holding AG's total assets of CHF1.21 Billion consist of 32.1% current assets and 67.9% non-current assets.

Asset Category	Amount (CHF)	% of Total Assets
Cash & Equivalents	CHF0.00	2.7%
Accounts Receivable	CHF203.48 Million	15.3%
Inventory	CHF85.75 Million	6.5%
Property, Plant & Equipment	CHF0.00	0.0%
Intangible Assets	CHF310.42 Million	23.3%
Goodwill	CHF0.00	0.0%

Asset Composition Trend (2002–2025)

This chart illustrates how Ypsomed Holding AG's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see YPSN market cap overview.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Ypsomed Holding AG's current assets represent 32.1% of total assets in 2025, a decrease from 38.2% in 2002.
Cash Position: Cash and equivalents constituted 2.7% of total assets in 2025, up from 1.7% in 2002.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 23.0% of total assets, an increase from 0.0% in 2002.
Asset Diversification: The largest asset category is intangible assets at 23.3% of total assets.

Ypsomed Holding AG Competitors by Total Assets

Key competitors of Ypsomed Holding AG based on total assets are shown below.

Company	Country	Total Assets
Alcon AG SW:ALC	Switzerland	CHF31.53 Billion
iRay Technology Co Ltd SHG:688301	China	CN¥11.33 Billion
Shenyang Xingqi Pharmaceutical Co Ltd SHE:300573	China	CN¥2.42 Billion
Anbio Biotechnology Class A Ordinary Shares NASDAQ:NNNN	USA	$32.49 Million
Jiangsu Nanfang Medical SHG:603880	China	CN¥993.46 Million
SDI Ltd AU:SDI	Australia	AU$141.20 Million
MEDIMI AB AK F:79T	Germany	€1.70 Million
I.Ceram SA PA:ALICR	France	€3.91 Million

Ypsomed Holding AG - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.47	0.66	0.62
Quick Ratio	1.19	0.51	0.40
Cash Ratio	0.14	0.10	0.07
Working Capital	CHF118.31 Million	CHF-172.25 Million	CHF-118.05 Million

Ypsomed Holding AG - Advanced Valuation Insights

This section examines the relationship between Ypsomed Holding AG's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	4.73
Latest Market Cap to Assets Ratio	2.89
Asset Growth Rate (YoY)	20.8%
Total Assets	CHF1.33 Billion
Market Capitalization	$3.85 Billion USD

Valuation Analysis

Premium Asset Valuation: The market values Ypsomed Holding AG's assets at a significant premium (2.89x), suggesting investors see substantial growth potential or unique competitive advantages.

Rapid Asset Growth: Ypsomed Holding AG's assets grew by 20.8% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Ypsomed Holding AG (2002–2025)

The table below shows the annual total assets of Ypsomed Holding AG from 2002 to 2025.

Year	Total Assets	Change
2025-03-31	CHF1.33 Billion ≈ $1.68 Billion	+20.79%
2024-03-31	CHF1.10 Billion ≈ $1.39 Billion	+27.79%
2023-03-31	CHF861.88 Million ≈ $1.09 Billion	+13.87%
2022-03-31	CHF756.91 Million ≈ $956.94 Million	+5.47%
2021-03-31	CHF717.68 Million ≈ $907.35 Million	+5.82%
2020-03-31	CHF678.24 Million ≈ $857.48 Million	+15.40%
2019-03-31	CHF587.75 Million ≈ $743.07 Million	+17.49%
2018-03-31	CHF500.24 Million ≈ $632.44 Million	+18.60%
2017-03-31	CHF421.80 Million ≈ $533.27 Million	+8.47%
2016-03-31	CHF388.87 Million ≈ $491.64 Million	+7.66%
2015-03-31	CHF361.21 Million ≈ $456.67 Million	+1.89%
2014-03-31	CHF354.53 Million ≈ $448.22 Million	+3.73%
2013-03-31	CHF341.79 Million ≈ $432.12 Million	+4.44%
2012-03-31	CHF327.27 Million ≈ $413.76 Million	-51.49%
2011-03-31	CHF674.63 Million ≈ $852.92 Million	+1.91%
2010-03-31	CHF662.01 Million ≈ $836.96 Million	+4.71%
2009-03-31	CHF632.22 Million ≈ $799.29 Million	-0.94%
2008-03-31	CHF638.23 Million ≈ $806.90 Million	+2.48%
2007-03-31	CHF622.79 Million ≈ $787.37 Million	-6.45%
2006-03-31	CHF665.70 Million ≈ $841.62 Million	+1.10%
2005-03-31	CHF658.48 Million ≈ $832.50 Million	+31.49%
2004-03-31	CHF500.78 Million ≈ $633.13 Million	+250.29%
2003-03-31	CHF142.96 Million ≈ $180.74 Million	+22.07%
2002-03-31	CHF117.12 Million ≈ $148.07 Million	--

About Ypsomed Holding AG

SW:YPSN Switzerland Medical Instruments & Supplies

Market Cap

$4.71 Billion

CHF3.73 Billion CHF

Market Cap Rank

#4249 Global

#62 in Switzerland

Share Price

CHF273.00

Change (1 day)

-0.73%

52-Week Range

CHF267.00 - CHF436.00

All Time High

CHF437.00